KIAA2012: A Drug Target / Disease Biomarker (G100652824)

Target Name: KIAA2012

NCBI ID: G100652824

KIAA2012

Other Name(s): K2012_HUMAN | Uncharacterized protein KIAA2012

KIAA2012: A Drug Target / Disease Biomarker

KIAA2012 is a protein that is expressed in many tissues throughout the body. It is a key regulator of the cell cycle, which means it helps keep cells organized and growing. It is also involved in the development and maintenance of cancer.

Research has shown that KIAA2012 is often high in cancer tissues, and that it is a potential drug target. This is because KIAA2012 has been shown to interact with a number of different proteins, which makes it a promising target for drug developers.

One of the main reasons why KIAA2012 is thought to be a good drug target is because it is involved in the regulation of the cell cycle. The cell cycle is the process by which cells grow and divide, and it is carefully controlled by a number of different proteins. KIAA2012 is one of these proteins, and it helps keep the cell cycle in check.

Studies have shown that KIAA2012 interacts with several different proteins, including the protein known as p21. p21 is a well-known cancer-related protein that helps prevent cells from dividing too often. KIAA2012 has been shown to work with p21 to keep the cell cycle running smoothly, which is important for cell growth and development.

Another reason why KIAA2012 is thought to be a good drug target is because it is involved in the development and maintenance of cancer. Many studies have shown that KIAA2012 is highly expressed in cancer tissues, and that it is involved in the development of cancer cells. This suggests that KIAA2012 could be a useful target for cancer drugs.

In addition to its involvement in the cell cycle and cancer development, KIAA2012 is also thought to be involved in the regulation of cell death. This is important because cell death is a critical part of normal cell function, and it is also important for the rejection of cancer cells.

Studies have shown that KIAA2012 interacts with the protein known as Bcl-2. Bcl-2 is a protein that helps protect cells from cell death, and it is often high in cancer tissues. KIAA2012 has been shown to work with Bcl-2 to keep cells alive, which is important for the rejection of cancer cells.

Overall, KIAA2012 is a protein that is involved in a number of important processes in the cell. As a result, it is a promising target for drug developers. Further research is needed to fully understand the role of KIAA2012 in the cell and its potential as a drug target.

Protein Name: KIAA2012

The "KIAA2012 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIAA2012 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets